Post-marketing Clinical Trial of Pioglitazone - A Study of Preventive Effects on the Onset and Recurrence of Macrovascular Events

Trial Profile

Post-marketing Clinical Trial of Pioglitazone - A Study of Preventive Effects on the Onset and Recurrence of Macrovascular Events

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Dec 2009

At a glance

  • Drugs Pioglitazone (Primary)
  • Indications Cardiovascular disorders; Type 2 diabetes mellitus; Vascular disorders
  • Focus Therapeutic Use
  • Sponsors Takeda
  • Most Recent Events

    • 10 Sep 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top